Allogeneic therapy (Allo)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic therapy (Allo), covering 2022-07-29 to 2022-07-29. Get the full timeline:
Most recent: Clinical Trial Update: Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102) [Phase 2]